In re Novo Nordisk Securities Litigation
Novo Nordisk Securities Litigation
3:17-cv-209-ZNQ-LHG

Important Documents

(To view/download a document, click its name.) Get Adobe Reader

Court Documents

Order Approving Distribution Plan, dated March 21, 2024 Order Approving Distribution Plan, dated March 21, 2024
Notice of Lead Plaintiffs' Motion for Approval of Distribution Plan, dated October 30, 2023 Notice of Lead Plaintiffs' Motion for Approval of Distribution Plan, dated October 30, 2023
Order and Judgement Approving Class Action Settlement, dated July 13, 2022 Order and Judgement Approving Class Action Settlement, dated July 13, 2022
Order Approving Plan of Allocation, dated July 13, 2022 Order Approving Plan of Allocation, dated July 13, 2022
Order Awarding Attorneys' Fees and Litigation Expense and Awards to Lead Plaintiffs Pursuant to 15 U.S.C. §78u-4(a)(4), dated July 13, 2022 Order Awarding Attorneys' Fees and Litigation Expense and Awards to Lead Plaintiffs Pursuant to 15 U.S.C. §78u-4(a)(4), dated July 13, 2022
Lead Plaintiffs' Reply Brief in Further Support of: (I) Motion for Final Approval of Settlement and Approval of Plan of Allocation; and (II) Motion for Attorneys' Fees and Litigation Expenses, and Awards to Lead Plaintiffs Pursuant to 15 U.S.C §78u-4(a)(4), dated June 21, 2022 Lead Plaintiffs' Reply Brief in Further Support of: (I) Motion for Final Approval of Settlement and Approval of Plan of Allocation; and (II) Motion for Attorneys' Fees and Litigation Expenses, and Awards to Lead Plaintiffs Pursuant to 15 U.S.C §78u-4(a)(4), dated June 21, 2022
Supplemental Declaration of Luiggy Segura Regarding Mailing of the Settlement Notice and Claim Form, dated June 16, 2022 Supplemental Declaration of Luiggy Segura Regarding Mailing of the Settlement Notice and Claim Form, dated June 16, 2022
Notice of Motion and Motion for Final Approval of Settlement and Approval of Plan of Allocation, Dated May 23, 2022 Notice of Motion and Motion for Final Approval of Settlement and Approval of Plan of Allocation, dated May 23, 2022
Notice of Motion and Motion for Attorneys' Fees and Litigation Expenses, and Awards to Lead Plaintiffs Pursuant to 15 U.S.C. §78u-4(a)(4), Dated May 23, 2022 Notice of Motion and Motion for Attorneys' Fees and Litigation Expenses, and Awards to Lead Plaintiffs Pursuant to 15 U.S.C. §78u-4(a)(4), dated May 23, 2022
Order Preliminarily Approving Settlement and Providing  for Notice, dated March 8, 2022 Order Preliminarily Approving Settlement and Providing  for Notice, dated March 8, 2022
List of Previously Excluded Parties List of Previously Excluded Parties
Stipulation and Agreement of Settlement, dated November 23, 2021 Stipulation and Agreement of Settlement, dated November 23, 2021
Order Granting Lead Plaintiffs' Unopposed Motion to Approve the Form and Manner of Class Notice, filed July 20, 2020 Order Granting Lead Plaintiffs' Unopposed Motion to Approve the Form and Manner of Class Notice, filed July 20, 2020

For More Information

Visit this website often to get the most up-to-date information.

Call
1-833-674-0167
Email
info@NovoNordiskSecuritiesLitigation.com
Mail

Novo Nordisk Securities Litigation
c/o JND Legal Administration
PO Box 91154
Seattle, WA 98111